These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 25343854

  • 21. [Salivary duct carcinomas comprise phenotypically and genotypically diverse high grade neoplasms].
    Hungermann D, Korsching E, Bürger H, Röser K, Löning T, Herbst H.
    Verh Dtsch Ges Pathol; 2006; 90():168-76. PubMed ID: 17867594
    [Abstract] [Full Text] [Related]

  • 22. Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type.
    Hsieh MS, Lee YH, Jin YT, Kuo YJ.
    Virchows Arch; 2020 Oct; 477(4):581-592. PubMed ID: 32383006
    [Abstract] [Full Text] [Related]

  • 23. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct?
    Skálová A, Ptáková N, Santana T, Agaimy A, Ihrler S, Uro-Coste E, Thompson LDR, Bishop JA, Baněčkova M, Rupp NJ, Morbini P, de Sanctis S, Schiavo-Lena M, Vanecek T, Michal M, Leivo I.
    Am J Surg Pathol; 2019 Oct; 43(10):1303-1313. PubMed ID: 31162284
    [Abstract] [Full Text] [Related]

  • 24. Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on tumoral heterogeneity and temporal concordance.
    Xu B, Dogan S, Haroon Al Rasheed MR, Ghossein R, Katabi N.
    Hum Pathol; 2019 Nov; 93():30-36. PubMed ID: 31430492
    [Abstract] [Full Text] [Related]

  • 25. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance.
    Nagao T, Gaffey TA, Visscher DW, Kay PA, Minato H, Serizawa H, Lewis JE.
    Am J Surg Pathol; 2004 Mar; 28(3):319-26. PubMed ID: 15104294
    [Abstract] [Full Text] [Related]

  • 26. Molecular patterns in salivary duct carcinoma identify prognostic subgroups.
    Mueller SA, Gauthier MA, Blackburn J, Grady JP, Kraitsek S, Hajdu E, Dettmer MS, Dahlstrom JE, Lee CS, Luk PP, Yu B, Giger R, Kummerfeld S, Clark JR, Gupta R, Cowley MJ.
    Mod Pathol; 2020 Oct; 33(10):1896-1909. PubMed ID: 32457410
    [Abstract] [Full Text] [Related]

  • 27. Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequent BAP1, PIK3CA, and other actionable genomic alterations.
    Wang K, McDermott JD, Schrock AB, Elvin JA, Gay L, Karam SD, Raben D, Somerset H, Ali SM, Ross JS, Bowles DW.
    Ann Oncol; 2017 Apr 01; 28(4):748-753. PubMed ID: 28327999
    [Abstract] [Full Text] [Related]

  • 28. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
    Gilbert MR, Sharma A, Schmitt NC, Johnson JT, Ferris RL, Duvvuri U, Kim S.
    JAMA Otolaryngol Head Neck Surg; 2016 May 01; 142(5):489-95. PubMed ID: 26939990
    [Abstract] [Full Text] [Related]

  • 29. Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.
    Luk PP, Weston JD, Yu B, Selinger CI, Ekmejian R, Eviston TJ, Lum T, Gao K, Boyer M, O'Toole SA, Clark JR, Gupta R.
    Head Neck; 2016 Apr 01; 38 Suppl 1():E1838-47. PubMed ID: 26699379
    [Abstract] [Full Text] [Related]

  • 30. CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis of the National Genomic Profiling Database.
    Kobayashi K, Saito Y, Kage H, Fukuoka O, Yamamura K, Mukai T, Oda K, Yamasoba T.
    Jpn J Clin Oncol; 2023 Aug 30; 53(9):798-807. PubMed ID: 37357968
    [Abstract] [Full Text] [Related]

  • 31. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.
    Bahrami A, Perez-Ordonez B, Dalton JD, Weinreb I.
    Histopathology; 2013 Aug 30; 63(2):250-62. PubMed ID: 23738717
    [Abstract] [Full Text] [Related]

  • 32. The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 cases.
    Urano M, Hirai H, Tada Y, Kawakita D, Shimura T, Tsukahara K, Kano S, Ozawa H, Okami K, Sato Y, Fushimi C, Shimizu A, Takase S, Okada T, Sato H, Imanishi Y, Otsuka K, Watanabe Y, Sakai A, Ebisumoto K, Togashi T, Ueki Y, Ota H, Sato Y, Saigusa N, Nakaguro M, Hanazawa T, Nagao T.
    Histopathology; 2018 Dec 30; 73(6):943-952. PubMed ID: 29993139
    [Abstract] [Full Text] [Related]

  • 33. Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review.
    Uijen MJM, Lassche G, van Engen-van Grunsven ACH, Tada Y, Verhaegh GW, Schalken JA, Driessen CML, van Herpen CML.
    Cancer Treat Rev; 2020 Sep 30; 89():102069. PubMed ID: 32717621
    [Abstract] [Full Text] [Related]

  • 34. Sarcomatoid variant of salivary duct carcinoma: clinicopathologic and immunohistochemical study of eight cases with review of the literature.
    Nagao T, Gaffey TA, Serizawa H, Iwaya K, Watanabe A, Yoshida T, Yamazaki K, Sageshima M, Lewis JE.
    Am J Clin Pathol; 2004 Aug 30; 122(2):222-31. PubMed ID: 15323139
    [Abstract] [Full Text] [Related]

  • 35. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.
    Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Löning T.
    Cancer; 2005 Jun 15; 103(12):2526-33. PubMed ID: 15900577
    [Abstract] [Full Text] [Related]

  • 36. Role of HER2 in Prognosis of Salivary Duct Carcinoma: A Systematic Review and Meta-Analysis.
    Williams CYK, Townson AT, Terry N, Schmitt NC, Sharma A.
    Laryngoscope; 2023 Mar 15; 133(3):476-484. PubMed ID: 35567387
    [Abstract] [Full Text] [Related]

  • 37. MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas.
    Grünewald I, Trautmann M, Busch A, Bauer L, Huss S, Schweinshaupt P, Vollbrecht C, Odenthal M, Quaas A, Büttner R, Meyer MF, Beutner D, Hüttenbrink KB, Wardelmann E, Stenner M, Hartmann W.
    Oncotarget; 2016 Nov 15; 7(46):75261-75272. PubMed ID: 27662657
    [Abstract] [Full Text] [Related]

  • 38. Immunohistochemical expression of mammaglobin in salivary duct carcinomas de novo and salivary duct carcinoma ex pleomorphic adenoma.
    Soares CD, de Lima Morais TM, Carlos R, Martins MD, de Almeida OP, Mariano FV, Altemani A.
    Hum Pathol; 2019 Oct 15; 92():59-66. PubMed ID: 31400353
    [Abstract] [Full Text] [Related]

  • 39. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
    Boon E, Bel M, van Boxtel W, van der Graaf WTA, van Es RJJ, Eerenstein SEJ, Baatenburg de Jong RJ, van den Brekel MWM, van der Velden LA, Witjes MJH, Hoeben A, Willems SM, Bloemena E, Smit LA, Oosting SF, PALGA Group, Jonker MA, Flucke UE, van Herpen CML.
    Int J Cancer; 2018 Aug 15; 143(4):758-766. PubMed ID: 29492965
    [Abstract] [Full Text] [Related]

  • 40. Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.
    Al-Qahtani KH, Tunio MA, Bayoumi Y, Gurusamy VM, Bahamdain FA, Fatani H.
    J Otolaryngol Head Neck Surg; 2016 May 16; 45(1):32. PubMed ID: 27184361
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.